Lixin Li

932 citations
36 papers · 712 indexed · h-index 16
Topics
MicroRNA in disease regulation (7 papers)Cancer-related molecular mechanisms research (6 papers)Circular RNAs in diseases (6 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsBrain Research
Partner nations
ChinaJapanUnited States

In The Last Decade

Lixin Li

33 papers receiving 708 citations

Peers

Lixin Li
Comparison fields: 5 of 83
  • Molecular Biology 426
  • Cancer Research 285
  • Immunology 74
  • Cellular and Molecular Neuroscience 69
  • Oncology 61
Replace Emmanuel Ampofo with:
Emmanuel Ampofo Germany
Jin An United States
Tatsuro Kanaki Japan
Shaonan Yang China
Hongfu Wu China
Yuqing Zhang China
Miaomei Yu China
Marc-André Déry Canada
Ching-Fang Chang Taiwan
Ying Yuan China
Lixin Li relative to Emmanuel Ampofo Germany Emmanuel Ampofo's profile →
Citations per field
00.5×1.5×2.4×
Emmanuel Ampofo · 1×
Citations per year

Countries citing papers authored by Lixin Li

Since Specialization
Citations

This map shows the geographic impact of Lixin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Li more than expected).

Fields of papers citing papers by Lixin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Li. The network helps show where Lixin Li may publish in the future.

Co-authorship network of co-authors of Lixin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lixin Li. A scholar is included among the top collaborators of Lixin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin Li. Lixin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 3
6 13
7 7
8 34
9 10
10 6
11 96
12 39
13 15
14 23
15 28
16 7
17 11
18 22
19 38
20
Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice.
12

About Lixin Li

Lixin Li is a scholar working on Cancer Research, Developmental Neuroscience and Neurology, having authored 36 papers that have together received 712 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (285 citations), Molecular Biology (426 citations) and Developmental Neuroscience (23 citations). Lixin Li has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xiaocheng Lu, Jinyu Zheng, Xi Wang, Kaixin Zhang, Ronglan Zhu, Baosheng Huang, Penglai Zhao, Zhongjun Chen, Shuai Li and Wei‐Zhong Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026